These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26563944)

  • 1. Production of Irbesartan Nanocrystals by High Shear Homogenisation and Ultra-Probe Sonication for Improved Dissolution Rate.
    Sridhar K; Rahman H; Sosnik A; Mukherjee U; Natarajan T; Siram K; Krishnamoorthy B
    Curr Drug Deliv; 2016; 13(5):688-97. PubMed ID: 26563944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin.
    Hirlekar R; Kadam V
    AAPS PharmSciTech; 2009; 10(1):276-81. PubMed ID: 19283492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of stable micron-sized crystalline irbesartan particles for the enhancement of dissolution rate.
    Zhang ZL; Le Y; Wang JX; Chen JF
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1357-64. PubMed ID: 21548718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility.
    Hirlekar RS; Sonawane SN; Kadam VJ
    AAPS PharmSciTech; 2009; 10(3):858-63. PubMed ID: 19562489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility, dissolution rate and bioavailability enhancement of irbesartan by solid dispersion technique.
    Boghra RJ; Kothawade PC; Belgamwar VS; Nerkar PP; Tekade AR; Surana SJ
    Chem Pharm Bull (Tokyo); 2011; 59(4):438-41. PubMed ID: 21467670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives.
    Chawla G; Bansal AK
    Acta Pharm; 2008 Sep; 58(3):257-74. PubMed ID: 19103563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
    Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
    Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of quercetin nanocrystals.
    Sahoo NG; Kakran M; Shaal LA; Li L; Müller RH; Pal M; Tan LP
    J Pharm Sci; 2011 Jun; 100(6):2379-90. PubMed ID: 21491450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inulin and poly(acrylic acid) grafted inulin for dissolution enhancement and preliminary controlled release of poorly water-soluble Irbesartan drug.
    Fares MM; Salem MS; Khanfar M
    Int J Pharm; 2011 May; 410(1-2):206-11. PubMed ID: 21421037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical-chemical properties of furosemide nanocrystals developed using rotation revolution mixer.
    Barbosa SF; Takatsuka T; Tavares GD; Araújo GL; Wang H; Vehring R; Löbenberg R; Bou-Chacra NA
    Pharm Dev Technol; 2016 Nov; 21(7):812-822. PubMed ID: 27825283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.
    Zhong L; Zhu X; Luo X; Su W
    AAPS PharmSciTech; 2013 Jun; 14(2):541-50. PubMed ID: 23430728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods.
    Sarnes A; Østergaard J; Jensen SS; Aaltonen J; Rantanen J; Hirvonen J; Peltonen L
    Eur J Pharm Sci; 2013 Nov; 50(3-4):511-9. PubMed ID: 23999036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
    Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
    Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.